MYNAVCARE BY GENMAB
Live / Registered — Registered (as of 03 Jun 2025)
What this means for you
Registered since 03 Jun 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97936794
- Registration number
- 7819914
- Mark type
- Stylized text
- Filed
- 15 May 2023
- Published for opposition
- 19 Mar 2024
- Registered
- 03 Jun 2025
- Attorney of record
- Max Vern
Goods and services
- Class 035 — Advertising and business services: Provision of consumer information in the field of patient reimbursement and medical benefit support; Business administrative services for medical referrals in connection to patient reimbursement programs; all in the field of treatment with monoclonal antibody anticancer medications; none of the above aimed at Massachusetts seniors who are Medicaid/MassHealth beneficiaries or are dual-eligible Medicare and Medicaid/MassHealth beneficiaries
- Class 036 — Insurance and financial services: Financial administration of patient reimbursement and patient financial assistance programs, namely reimbursement payment processing in the field of pharmaceutical and medical claims; Charitable services, namely, providing financial support to disadvantaged patients for the purpose of reimbursing medical and pharmaceutical expenses; Providing counseling and consulting in the field of healthcare insurance benefits in connection with patient reimbursement and patient financial assistance programs; Providing information about healthcare insurance plans, patient financial assistance, and patient reimbursement programs; all in the field of treatment with monoclonal antibody anticancer medications; none of the above aimed at Massachusetts seniors who are Medicaid/MassHealth beneficiaries or are dual-eligible Medicare and Medicaid/MassHealth beneficiaries
- Class 044 — Medical, beauty and agricultural services: Medical assistance, namely disease management programs; provision of health care information in connection to disease management and navigation through medical treatments; provision of medical information in connection with health conditions and treatment of these conditions; medical counseling for patients in connection with disease management; Consultancy in the field of the medical treatment of cancer, autoimmune diseases, and inflammatory disorders; providing information to patients and families of patients in the field of administering medication and choosing treatments; providing a website featuring information in the medical and health fields in connection to disease management and navigation through medical treatments; health care services, namely disease management programs; medical and pharmaceutical consultation in connection to disease management; medical services, namely, provision of medical information for supporting patients in relation to the reimbursement of medical expenses; Providing a web site featuring medical information for patients in relation to the reimbursement of medical expenses; all in the field of treatment with monoclonal antibody anticancer medications; none of the above aimed at Massachusetts seniors who are Medicaid/MassHealth beneficiaries or are dual-eligible Medicare and Medicaid/MassHealth beneficiaries
Owner
- Genmab A/S, Valby, DK
- Genmab A/S, Valby, DK
- Genmab A/S, Valby, DK
Prosecution history
- 03 Jun 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 03 Jun 2025 — REGISTERED-PRINCIPAL REGISTER
- 09 May 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 09 May 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 28 Apr 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 28 Apr 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 25 Apr 2025 — ASSIGNED TO LIE
- 08 Apr 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 13 Feb 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 13 Feb 2025 — NON-FINAL ACTION E-MAILED
- 13 Feb 2025 — SU - NON-FINAL ACTION - WRITTEN
- 24 Jan 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 08 Nov 2024 — USE AMENDMENT FILED
- 24 Jan 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 08 Nov 2024 — TEAS STATEMENT OF USE RECEIVED